Patent ID: 7811772

Claim:
A method for screening for prostate cancer or benign prostate hyperplasia in a subject comprising the steps of: (a) providing a biological sample of a human physiological fluid or prostate tissue from the subject; (b) contacting the biological sample with an antibody capable of capturing an ApoA-II isoform comprising: (i) amino acid sequence VKSPELQAEAK (SEQ ID NO:1); and (ii) amino acid sequence SKEQLTPLIK (SEQ ID NO:2); (c) determining the amount of the bound ApoA-II isoform having a molecular weight of about 8943 Dalton +/−15; and (d) correlating the amount of the bound ApoA-II isoform having a molecular weight of about 8943 Dalton +/−15 to a status of prostate cancer or benign prostate hyperplasia.